APC
APC (APC regulator of Wnt signalling pathway, also known as DP2, DP3, DP2.5 and PPP1R46) is a tumour suppressor that antagonises Wnt signalling by promoting degradation of CTNNB1. It also associates with the microtubule and actin cytoskeleton. Browse Assay Genie's current range of APC research reagents below, or read on for the biology behind the target.
APC is a tumour suppressor that acts as a negative regulator of the Wnt signalling pathway. It promotes the rapid degradation of CTNNB1 (beta-catenin), and its activity is correlated with its phosphorylation state. Beyond Wnt signalling, APC activates the GEF activity of SPATA13 and ARHGEF4, contributes to hepatocyte growth factor (HGF)-induced cell migration, and is required for MMP9 up-regulation through the JNK signalling pathway in colorectal tumour cells.
The APC protein associates with both microtubules and actin filaments. It helps organise F-actin into ordered bundles, and it functions downstream of Rho GTPases and DIAPH1 to selectively stabilise microtubules. APC also mediates ERBB2-dependent microtubule stabilisation at the cell cortex, and it is required for the localisation of MACF1 to the cell membrane, which is critical for MACF1 function in microtubule stabilisation. UniProt records the protein in the cytoplasm and cytoskeleton, at adherens junctions, in lamellipodia and ruffle membranes, and at the cell membrane.
The APC gene is a member of the adenomatous polyposis coli (APC) family and belongs to the HGNC groups of armadillo repeat containing proteins and protein phosphatase 1 regulatory subunits, hence the alias PPP1R46. Defects in the gene cause familial adenomatous polyposis (FAP), an autosomal dominant pre-malignant disease that usually progresses to malignancy. Mutations in APC occur in most colorectal cancers; they tend to cluster in a small region called the mutation cluster region (MCR) and result in a truncated protein product. NCBI Gene also links APC to cell adhesion, transcriptional activation and apoptosis.
APC is a negative regulator of Wnt signalling that promotes CTNNB1 degradation, making it central to studies of pathway control.
APC mutations occur in most colorectal cancers and typically yield a truncated protein, so it is a key subject in tumour studies.
Defects in the APC gene cause familial adenomatous polyposis, an autosomal dominant pre-malignant disease that usually progresses to malignancy.
APC binds microtubules and actin, stabilises microtubules downstream of Rho GTPases and DIAPH1, and contributes to HGF-induced cell migration.
APC is a tumour suppressor that negatively regulates Wnt signalling by promoting rapid degradation of CTNNB1. It also binds microtubules and actin filaments, organises F-actin into bundles, stabilises microtubules and supports cell migration, with activity correlated with its phosphorylation state.
The HGNC name is APC regulator of Wnt signalling pathway, and the UniProt name is adenomatous polyposis coli protein. Aliases and previous symbols include DP2, DP3, DP2.5 and PPP1R46. Earlier names include adenomatosis polyposis coli and APC, WNT signalling pathway regulator.
Yes. Defects in the APC gene cause familial adenomatous polyposis, and mutations are found in most colorectal cancers. Mouse and rat both have an Apc ortholog. Check the datasheet of any product for its validated reactivity.
Related targets and pathway partners with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P25054; product specifications from Assay Genie datasheets.